Skip to main content

Webcasts & Webinars

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Elevate your practice with exclusive CME webinars, medical congress coverage, and educational content

Join a network of dedicated doctors and unlock full access to webinars, in-depth congress coverage, and a vast library of educational resources.

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video

On-demand video

Video

New indications for anti-amyloid antibody therapies

Juan Fortea comments on future opportunities for anti-amyloid antibody treatment given the consolidation of clinical trial data in the real world.

Supported by:
  • Lilly
Video

Implications of latest data on anti-amyloid antibody therapies

Claire Paquet discusses the implications of the real-world and recommendation data presented on anti-amyloid antibody therapies for Alzheimer’s disease.

Supported by:
  • Lilly
Video

Real-world experience with amyloid-targeting treatments and preparedness for fluid biomarkers in practice

Gemma Salvadó, Sharon A Brangman, and Argonde van Harten explore what the latest developments from AAIC 2024 mean for clinical practice. How can blood-based biomarkers best be applied? What should you consider when selecting patients for amyloid-targeting therapies?

Supported by:
  • Lilly
Video

Implementing AD biomarkers and amyloid-targeting therapies

Dorota Religa and Robert Perneczky walk us through the most exciting findings from the AD/PD™ and CONy 2024 conferences. Their discussion focuses on existing and emerging biomarkers and new amyloid-targeting therapies in Alzheimer's disease.

Supported by:
  • Lilly
Video

Novel clinical evidence in continuous glucose monitoring

Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.

Supported by:
  • Abbott Diabetes Care
Video

ctDNA and bladder cancer: Current understanding and beyond

Urologist James Catto asks oncologist Thomas Powles key questions on the role of ctDNA in the understanding of urothelial cancer and its potential to improve treatment decision-making in the future.

Supported by:
  • F. Hoffmann-La Roche Ltd.

New on-demand webinar

Incorporating comprehensive genomic profiling into the standard-of-care for NSCLC and thyroid cancer

In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations.

This content is intended only for US-based healthcare providers.

Supported by:
  • Illumina, Inc., and Eli Lilly and Company
Dr. Vivek Subbiah
Dr. Alexander Drilon
Dr. Michelle Williams
Developed by: Springer Healthcare
Watch now
Video

On-demand CME webinars

Video
SPONSORED

Targeting COPD with type 2 inflammation: emerging biologic landscape

1.5 European CME credits (ECMEC®s)

Watch an insightful session tailored for pulmonologists and healthcare professionals eager to enhance their understanding of COPD and the latest advances in biologic therapies.

Sponsored by:
  • Sanofi
Developed by: Springer Healthcare
Video
SPONSORED

Challenges in advanced CTCL – diagnosis and management

1.5 European CME credits (ECMEC®s)

In this interactive webinar, a multidisciplinary team of speakers provide practical guidance on managing patients with cutaneous T-cell lymphoma. Learn about the key aspects of diagnosis and treatment via a series of patient cases. 

Sponsored by:
  • Kyowa Kirin
Developed by: Springer Healthcare
Video
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

1.5 European CME credits (ECMEC®s) 

Severe pain is the most common symptom of chronic pancreatitis. In this live webinar, experts shared the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discussed pertinent cases and provided practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now
Video

Coverage of ESMO Congress 2024

Video

Researcher comment on the HypoG-01 trial

Watch as Dr. Sofia Rivera explains why the HypoG-01 trial will change how radiotherapy is administered in patients with locoregional early breast cancer.

Video

Expert comment on the NIAGARA trial

Dive into the NIAGARA trial of perioperative durvalumab with Dr. Petros Grivas as he outlines the key findings and implications for managing muscle-invasive bladder cancer. 

Video

Researcher comment on the KEYNOTE-A18 trial

Watch as Prof. Domenica Lorusso outlines the positive overall survival data from KEYNOTE-A18, reinforcing the benefit of add-on pembrolizumab in locally advanced cervical cancer.

Video

Scientific Congress Highlights: Genitourinary tumours, prostate

Dr. Ursula Vogl outlines the main prostate cancer studies that caught her attention at ESMO 2024, and provides context and commentary on the findings. 

Video

Scientific Congress Highlights: Gastrointestinal tumours, upper digestive

Dr. Sarah Derks takes us through the key studies in gastroesophageal, liver, and pancreatic cancer presented at ESMO 2024, discussing the results and clinical implications.

Video

Scientific Congress Highlights: Genitourinary tumours, non-prostate

Dr. Ignacio Duran shares his highlights of the non-prostate genitourinary tumors presentations at ESMO 2024, and summarizes the most relevant new information about bladder and kidney cancer.

Coverage of ESC Congress 2024

Video

Management of obesity in cardiac patients: what cardiologists should know

In this official video from the ESC 2024 Congress, Prof Niklaus Marx explains what every cardiologist needs to consider when working with patients with obesity. With a focus on the ESC consensus statement on obesity and CVD, Prof Marx offers useful tips for effective management of this increasingly common population in your cardiology clinic.

Video

NEW ESC Guideline: managing elevated blood pressure and hypertension

Dr. Rhian Touyz takes us through the main features of the new ESC guidelines on the management of elevated blood pressure and hypertension, including a new blood pressure category and more ambitious and intensive treatment targets.

Video

NEW ESC Guideline: managing peripheral arterial and aortic diseases

Professor Lucia Mazzolai outlines the key recommendations from the new ESC guidelines on peripheral arterial and aortic diseases, such as the importance of screening, emphasis on exercise and lifestyle changes, and optimal pharmacological treatment.

Video

NEW ESC Guideline: managing atrial fibrillation

Professor Dipak Kotecha gives an overview of the new ESC guidelines on atrial fibrillation, highlighting the importance of shared decision-making and the new AF-CARE pathway to optimize patient care.

Video

Researcher comment on MRAs in heart failure

Professor Pardeep Jhund shares the main findings of their meta-analysis of mineralocorticoid receptor antagonists in heart failure, based on data from the RALES, EMPHASIS-HF, TOPCAT, and FINEARTS-HF trials.

Video

Researcher comment on the TIGHT-K trial

Professor Benjamin O'Brien discusses the TIGHT-K study results, which indicate that routine potassium supplementation can be avoided after isolated coronary artery bypass graft surgery.

Video

Researcher comment on the ABYSS trial

Professor Johanne Silvain takes us through the main findings of the ABYSS study, which evaluated the safety of beta-blocker interruption versus continuation in people with a history of myocardial infarction.